Please assess the completion status of the following clinical trial:

Trial Title: F38-27: An Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Male or female outpatients who are undergoing colonoscopy for a routinely accepted indications:~2. At least 18 years of age~3. Otherwise in good health, as determined by physical exam and medical history~4. If female, and of child-bearing potential, is using an acceptable form of birth control~5. Negative urine pregnancy test at screening, if applicable~6. In the Investigator's judgment, subject is mentally competent to provide informed consent to participate in the study~Exclusion Criteria:~1. Subjects with known or suspected ileus, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis, or toxic megacolon~2. Subjects with impaired consciousness that predisposes them to pulmonary aspiration~3. Subjects who are undergoing colonoscopy for foreign body removal and decompression~4. Subjects with pre-existing electrolyte disturbances, such as dehydration, or those secondary to the use of diuretics~5. Subjects who are taking drugs that may affect electrolyte levels with the exception of routine diuretics~6. Subjects with known clinically significant electrolyte abnormalities such as hypernatremia, hyperphosphatemia, hypokalemia, or hypocalcemia~7. Subjects who are pregnant or lactating, or intending to become pregnant during the study~8. Subjects of childbearing potential who refuse a pregnancy test~9. Subjects who are allergic to any preparation components~10. Subjects who, in the opinion of the Investigator, should not be included in the study for any reason, including inability to follow study procedures~11. Subjects who have participated in an investigational clinical, surgical, drug, or device study within the past 30 days

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- HalfLytely with 10mg bisacodyl (Type: ACTIVE_COMPARATOR): Active control
- HalfLytely with 5mg bisacodyl (Type: EXPERIMENTAL): Investigational dose

Based on this trial design, predict the completion outcome and termination type (if applicable).